TRAVELLI, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 1.191
AS - Asia 822
EU - Europa 585
SA - Sud America 136
Continente sconosciuto - Info sul continente non disponibili 103
AF - Africa 65
OC - Oceania 3
Totale 2.905
Nazione #
US - Stati Uniti d'America 1.156
SG - Singapore 248
CN - Cina 216
HK - Hong Kong 139
IE - Irlanda 127
RU - Federazione Russa 110
BR - Brasile 109
IT - Italia 101
VN - Vietnam 84
DE - Germania 75
FR - Francia 46
FI - Finlandia 43
ZA - Sudafrica 35
GB - Regno Unito 31
IN - India 30
BD - Bangladesh 18
IQ - Iraq 16
CA - Canada 12
JP - Giappone 12
MX - Messico 12
AR - Argentina 10
BE - Belgio 9
ES - Italia 9
MA - Marocco 8
CM - Camerun 7
CO - Colombia 7
ID - Indonesia 6
PH - Filippine 6
PK - Pakistan 6
SA - Arabia Saudita 6
TR - Turchia 6
AT - Austria 5
EG - Egitto 5
LT - Lituania 4
PL - Polonia 4
SE - Svezia 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
EC - Ecuador 3
JO - Giordania 3
KE - Kenya 3
KR - Corea 3
MY - Malesia 3
NL - Olanda 3
NP - Nepal 3
AL - Albania 2
AU - Australia 2
AZ - Azerbaigian 2
CH - Svizzera 2
DZ - Algeria 2
GE - Georgia 2
PE - Perù 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UA - Ucraina 2
BB - Barbados 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GF - Guiana Francese 1
GP - Guadalupe 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
MD - Moldavia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
SI - Slovenia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 2.802
Città #
San Jose 193
Hong Kong 138
Ashburn 133
Singapore 130
Dublin 127
Chandler 113
Dallas 96
Council Bluffs 83
Beijing 79
Boardman 41
Lauterbourg 40
Munich 40
Johannesburg 30
Los Angeles 30
Redondo Beach 30
Ho Chi Minh City 29
Helsinki 25
New York 22
Shanghai 21
Buffalo 20
Orem 20
Moscow 19
Columbus 18
The Dalles 18
Turku 18
Hanoi 16
Ann Arbor 15
Falkenstein 15
Lawrence 15
Princeton 15
Milan 14
São Paulo 14
Nuremberg 13
Santa Clara 12
Medford 11
Chicago 10
Tokyo 10
Baghdad 9
Bolzaneto 9
Brussels 9
Wilmington 9
Turin 8
Guangzhou 7
Rome 7
Brooklyn 6
Da Nang 6
Manchester 6
Mexico City 5
Mumbai 5
San Francisco 5
Bossico 4
Fortaleza 4
Norwalk 4
Novara 4
Rio de Janeiro 4
Seattle 4
Washington 4
Yaoundé 4
Biên Hòa 3
Boston 3
Casablanca 3
Charlotte 3
Chennai 3
Douala 3
Haiphong 3
Hangzhou 3
Houston 3
Inverigo 3
Jeddah 3
Joinville 3
Londrina 3
Medellín 3
Montreal 3
Nairobi 3
Richmond 3
Salvador 3
Seoul 3
Shijiazhuang 3
Stockholm 3
Tianjin 3
Toronto 3
Warsaw 3
Amman 2
Ankara 2
Atlanta 2
Augusta 2
Barbianello 2
Barra Mansa 2
Belo Horizonte 2
Bengaluru 2
Brasília 2
Bắc Ninh 2
Cairo 2
Des Moines 2
Duque de Caxias 2
Durban 2
Faisalabad 2
Genoa 2
Greensboro 2
Gurugram 2
Totale 1.904
Nome #
OXER1 and RACK1-associated pathway: a promising drug target for breast cancer progression 125
Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitis 108
Ribosomes as a nexus between translation and cancer progression: Focus on ribosomal Receptor for Activated C Kinase 1 (RACK1) in breast cancer 101
Disruption of epithelial barrier integrity via altered GILZ/c-Rel/RACK1 signaling in inflammatory bowel disease (IBD) 96
Design, synthesis, and biological evaluation of combretabenzodiazepines: A novel class of anti-tubulin agents 96
Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual Screening to in Vivo Pharmacodynamic Activity 95
A nicotinamide phosphoribosyltransferase–GAPDH interaction sustains the stress-induced NMN/NAD+ salvage pathway in the nucleus 92
Identification of Novel Triazole-Based Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors Endowed with Antiproliferative and Antiinflammatory Activity 92
Increased plasma nicotinamide phosphoribosyltransferase is associated with a hyperproliferative phenotype and restrains disease progression in MPN-associated myelofibrosis 91
Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) neutralization counteracts T cell immune evasion in breast cancer 89
Nicotinamide phosphoribosyltransferase acts as a metabolic gate for mobilization of myeloid-derived suppressor cells 87
Data on metabolic stability, aqueous solubility and CYP inhibition of novel triazole-based nicotinamide phosphoribosyltransferase (NAMPT) inhibitors 87
Molecular regulations of circadian rhythm and implications for physiology and diseases 83
Identification of potent triazolylpyridine nicotinamide phosphoribosyltransferase (NAMPT) inhibitors bearing a 1,2,3-triazole tail group 83
Mucosal Overexpression of Thymic Stromal Lymphopoietin and Proinflammatory Cytokines in Patients With Autoimmune Atrophic Gastritis 82
Molecular characterization of membrane steroid receptors in hormone-sensitive cancers 82
The Cytokine Nicotinamide Phosphoribosyltransferase (eNAMPT; PBEF; Visfatin) Acts as a Natural Antagonist of C-C Chemokine Receptor Type 5 (CCR5) 81
Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is a tumoural cytokine released from melanoma 76
Recent Advances in NAMPT Inhibitors: A Novel Immunotherapic Strategy 74
Prostaglandin E2 and cancer: Insight into tumor progression and immunity 73
Involvement of eNAMPT/TLR4 inflammatory signaling in progression of non-alcoholic fatty liver disease, steatohepatitis, and fibrosis 72
eNAMPT/TLR4 inflammatory cascade activation is a key contributor to SLE Lung vasculitis and alveolar hemorrhage 69
Extracellular nicotinamide phosphoribosyltransferase boosts IFNγ-induced macrophage polarization independently of TLR4 61
Autophagy and inflammation an intricate affair in the management of obesity and metabolic disorders: evidence for novel pharmacological strategies? 58
A novel potent nicotinamide phosphoribosyltransferase inhibitor synthesized via click chemistry 58
Identification of novel aza-analogs of TN-16 as disrupters of microtubule dynamics through a multicomponent reaction 58
Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine 56
Pro- and anti-inflammatory cytokines: the hidden keys to autoimmune gastritis therapy 55
Insight Into Nicotinamide Adenine Dinucleotide Homeostasis as a Targetable Metabolic Pathway in Colorectal Cancer 55
NAMPT: A pleiotropic modulator of monocytes and macrophages 55
Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors 54
NAMPT and NAPRT serum levels predict response to anti-TNF therapy in inflammatory bowel disease 52
NAD depletion by FK866 induces autophagy 47
Identification of a novel NAMPT inhibitor by combinatorial click chemistry and chemical refinement 45
Targeting Transient Receptor Potential Vanilloid 1 (TRPV1) Channel Softly: The Discovery of Passerini Adducts as a Topical Treatment for Inflammatory Skin Disorders 45
Metabolic regulation of suppressive myeloid cells in cancer 44
The NAMPT inhibitor FK866 reverts the damage in spinal cord injury 44
Triazole-curcuminoids: A new class of derivatives for 'tuning' curcumin bioactivities? 44
Characterization of NAD uptake in mammalian cells 42
Synthesis and Degradation of Adenosine 5′-Tetraphosphate by Nicotinamide and Nicotinate Phosphoribosyltransferases 35
Reciprocal potentiation of the antitumoral activities of FK866, an inhibitor of nicotinamide phosphoribosyltransferase, and etoposide or cisplatin in neuroblastoma cells 34
Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions 29
Totale 2.905
Categoria #
all - tutte 14.002
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.002


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202296 0 1 1 0 2 1 0 7 5 1 10 68
2022/2023317 17 34 15 22 22 34 0 18 143 2 8 2
2023/2024108 9 13 6 11 17 29 0 20 1 1 0 1
2024/2025710 38 45 10 49 2 48 62 30 155 18 111 142
2025/20261.543 126 111 164 125 203 51 280 82 134 131 104 32
2026/2027111 31 80 0 0 0 0 0 0 0 0 0 0
Totale 2.905